Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus

The goal of this study was to explore the association between Src homology 3 domain of SH3 domain containing Ysc84-like 1 (SH3YL1) protein and diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). The study included 90 participants, 60 patients with T2DM all recruited from Outpatients Clinic...

Full description

Bibliographic Details
Main Authors: Shimaa Gomaa, Rania Sheir, Hanan Farhan, Thoraya Ahmed, Ahmed Abdelsattar
Format: Article
Language:English
Published: Beni-Suef University, Faculty of Medicine 2022-07-01
Series:Egyptian Journal of Medical Research
Subjects:
Online Access:https://ejmr.journals.ekb.eg/article_259455_4f4efc683d61a25bfb5f8221efd4f22f.pdf
_version_ 1828003628168773632
author Shimaa Gomaa
Rania Sheir
Hanan Farhan
Thoraya Ahmed
Ahmed Abdelsattar
author_facet Shimaa Gomaa
Rania Sheir
Hanan Farhan
Thoraya Ahmed
Ahmed Abdelsattar
author_sort Shimaa Gomaa
collection DOAJ
description The goal of this study was to explore the association between Src homology 3 domain of SH3 domain containing Ysc84-like 1 (SH3YL1) protein and diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). The study included 90 participants, 60 patients with T2DM all recruited from Outpatients Clinic and Internal Medicine Inpatient Department, Beni-Suef University Hospital; and 30 apparently healthy controls. Patients were sub-divided into group I: 20 patients with no albuminuria, group II: 20 patients with microalbuminuria and group III: 20 patients with macroalbuminuria. All participants were subjected to full history taking, routine laboratory investigations and serum SH3YL1 analysis using enzyme-linked immunosorbent (ELISA) assay. Serum SH3YL1  was significantly higher in T2DM patients (5.69 ± 1.6 ng/ml) versus controls (3.76 ±0.80 ng/ml) (p<0.001).There was  statistical significant difference with p <0.05 between cases of group I, and each of group II, and group III as regards SH3YL1 level with lowest mean among group I. There was statistical significant positive correlation between SH3YL1 level and each of fasting blood glucose, 2hours postprandial, glycated hemoglobin, urea, creatinine, albuminuria, total cholesterol and triglycerides. SH3YL1 showed sensitivity of (88.3%) and specificity of (53.3%) at cut off value (3.85 ng/mL) among T2DM patients versus controls (p<0.001). Moreover, sensitivity of (70%, 90%, and 90%) and specificity of (56.7%, 70%, and 86.7%) at cutoff (4 ng/mL, 4.45 ng/mL, and 4.65 ng/mL) was found among groups I, II and III versus control group (p= 0.01, <0.001 and <0.001), respectively. In conclusion, SH3YL1 serum level revealed statistically significant increase among T2DM patients and showed statistical difference between the studied no albuminuria, microalbuminuria and macroalbuminuria groups. Our study suggests SH3YL1 as a promising diagnostic and prognostic marker among DN patients.
first_indexed 2024-04-10T07:01:37Z
format Article
id doaj.art-56b3394cb15d4492871f2331817c9822
institution Directory Open Access Journal
issn 2682-4396
2682-440X
language English
last_indexed 2024-04-10T07:01:37Z
publishDate 2022-07-01
publisher Beni-Suef University, Faculty of Medicine
record_format Article
series Egyptian Journal of Medical Research
spelling doaj.art-56b3394cb15d4492871f2331817c98222023-02-27T17:41:50ZengBeni-Suef University, Faculty of MedicineEgyptian Journal of Medical Research2682-43962682-440X2022-07-013322223710.21608/ejmr.2022.259455259455Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitusShimaa Gomaa0Rania Sheir1Hanan Farhan2Thoraya Ahmed3Ahmed Abdelsattar4Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptClinical and Chemical Pathology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptInternal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptThe goal of this study was to explore the association between Src homology 3 domain of SH3 domain containing Ysc84-like 1 (SH3YL1) protein and diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). The study included 90 participants, 60 patients with T2DM all recruited from Outpatients Clinic and Internal Medicine Inpatient Department, Beni-Suef University Hospital; and 30 apparently healthy controls. Patients were sub-divided into group I: 20 patients with no albuminuria, group II: 20 patients with microalbuminuria and group III: 20 patients with macroalbuminuria. All participants were subjected to full history taking, routine laboratory investigations and serum SH3YL1 analysis using enzyme-linked immunosorbent (ELISA) assay. Serum SH3YL1  was significantly higher in T2DM patients (5.69 ± 1.6 ng/ml) versus controls (3.76 ±0.80 ng/ml) (p<0.001).There was  statistical significant difference with p <0.05 between cases of group I, and each of group II, and group III as regards SH3YL1 level with lowest mean among group I. There was statistical significant positive correlation between SH3YL1 level and each of fasting blood glucose, 2hours postprandial, glycated hemoglobin, urea, creatinine, albuminuria, total cholesterol and triglycerides. SH3YL1 showed sensitivity of (88.3%) and specificity of (53.3%) at cut off value (3.85 ng/mL) among T2DM patients versus controls (p<0.001). Moreover, sensitivity of (70%, 90%, and 90%) and specificity of (56.7%, 70%, and 86.7%) at cutoff (4 ng/mL, 4.45 ng/mL, and 4.65 ng/mL) was found among groups I, II and III versus control group (p= 0.01, <0.001 and <0.001), respectively. In conclusion, SH3YL1 serum level revealed statistically significant increase among T2DM patients and showed statistical difference between the studied no albuminuria, microalbuminuria and macroalbuminuria groups. Our study suggests SH3YL1 as a promising diagnostic and prognostic marker among DN patients.https://ejmr.journals.ekb.eg/article_259455_4f4efc683d61a25bfb5f8221efd4f22f.pdfsh3yl1biomarkerdiabetic nephropathytype 2 diabetes mellitus
spellingShingle Shimaa Gomaa
Rania Sheir
Hanan Farhan
Thoraya Ahmed
Ahmed Abdelsattar
Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
Egyptian Journal of Medical Research
sh3yl1
biomarker
diabetic nephropathy
type 2 diabetes mellitus
title Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
title_full Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
title_fullStr Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
title_full_unstemmed Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
title_short Assessment of SH3YL1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
title_sort assessment of sh3yl1 protein as a marker for diabetic nephropathy in type 2 diabetes mellitus
topic sh3yl1
biomarker
diabetic nephropathy
type 2 diabetes mellitus
url https://ejmr.journals.ekb.eg/article_259455_4f4efc683d61a25bfb5f8221efd4f22f.pdf
work_keys_str_mv AT shimaagomaa assessmentofsh3yl1proteinasamarkerfordiabeticnephropathyintype2diabetesmellitus
AT raniasheir assessmentofsh3yl1proteinasamarkerfordiabeticnephropathyintype2diabetesmellitus
AT hananfarhan assessmentofsh3yl1proteinasamarkerfordiabeticnephropathyintype2diabetesmellitus
AT thorayaahmed assessmentofsh3yl1proteinasamarkerfordiabeticnephropathyintype2diabetesmellitus
AT ahmedabdelsattar assessmentofsh3yl1proteinasamarkerfordiabeticnephropathyintype2diabetesmellitus